Trademark: 79255966
Word
BENEVOLENTAI
Status
Registered
Status Code
700
Status Date
Tuesday, April 7, 2020
Serial Number
79255966
Registration Number
6026106
Registration Date
Tuesday, April 7, 2020
Mark Type
4000
Filing Date
Tuesday, February 5, 2019
Published for Opposition
Tuesday, January 21, 2020

Trademark Owner History
BenevolentAI Limited - Original Registrant

Classifications
41 Library services provided by means of a computerized database; library services, namely, providing electronic library services featuring data stored and retrieved by electronic means; publication of books; publication of journals; publication of electronic books and journals online; publication of material in the nature of electronic books and journals which can be accessed from databases or from the Internet; publication of the results of clinical trials for pharmaceutical preparations in the field of diseases affecting the central nervous system; publication of the results of clinical trials for pharmaceutical preparations
9 Artificial intelligence apparatus, namely, computer hardware and recorded software for implementing artificial intelligence in products and services; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines
5 Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations acting on the central nervous system; medicines for the treatment of diseases affecting the central nervous system; medicines for veterinary purposes in the nature of antibiotics; antibiotics for human use; antibiotics for veterinary use; antibiotic food supplements for animals; chemical reagents for medical use; chemical reagents for veterinary use; central nervous system stimulants; nutritional supplements; nutritional supplements for veterinary use; vitamin and mineral supplements; vitamin supplements for animals; veterinary vaccines
44 Healthcare information, advisory and consultancy services; medical services; medical information, advisory and consultancy services; medical testing for diagnostic or treatment purposes; consulting services in the fields of pharmaceutical research and development; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; consulting and advisory services in the fields of pharmaceutical research and development; veterinary services; veterinary information, advisory and consultancy services; collation of information in the healthcare sector; providing medical information in the healthcare sector; providing medical information concerning pharmaceuticals and the research and development of pharmaceuticals, all of the aforesaid services also provided online via a database or the Internet
10 Medical instruments for therapeutic drug monitoring; testing apparatus for DNA and RNA testing for medical purposes
42 Design and development of computer software; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the field of healthcare; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Platform as a Service [PaaS], namely, providing artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the field of healthcare; Platform as a Service [PaaS], namely, providing artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Software as a Service [SaaS], namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare; Software as a Service [SaaS], namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; hosting of digital content online; hosting of digital content, namely, online journals; computer programming; writing of computer programs for medical applications; writing of computer programs for biotechnological applications; writing of data processing programs; scientific and medical research and development services; scientific research conducted using databases and the Internet; medical research services; pharmaceutical research and development services; pharmaceutical product evaluation; research and development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; drug discovery services; services for assessing the efficiency of veterinary drugs; services for assessing the efficiency of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of pharmaceutical research and development; information technology consulting services for the pharmaceutical and healthcare industries; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information, advisory and consultancy services regarding information technology services for the pharmaceutical and healthcare industries, all of the aforesaid services also provided online via a database or the Internet; providing information, advisory and consultancy services regarding research and development of pharmaceutical preparations and medicines, all of the aforesaid services also provided online via a database or the Internet; providing information and data relating to veterinary research and development, all of the aforesaid services also provided online via a database or the Internet
BENEVOLENT AI

Trademark Events
Jul 15, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 15, 2022
Teas Change Of Correspondence Received
Jul 15, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Jul 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 15, 2022
Teas Change Of Owner Address Received
Mar 16, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 16, 2022
Teas Change Of Correspondence Received
Mar 16, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 16, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 16, 2022
Teas Change Of Owner Address Received
Aug 29, 2020
Final Decision Transaction Processed By Ib
Aug 12, 2020
Final Disposition Notice Sent To Ib
Aug 12, 2020
Final Disposition Processed
Jul 30, 2020
New Representative At Ib Received
Jul 7, 2020
Final Disposition Notice Created, To Be Sent To Ib
Apr 7, 2020
Registered-Principal Register
Jan 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 21, 2020
Published For Opposition
Jan 17, 2020
Notification Processed By Ib
Jan 1, 2020
Notification Of Possible Opposition Sent To Ib
Jan 1, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 1, 2020
Notification Of Notice Of Publication E-Mailed
Dec 19, 2019
Assigned To Lie
Dec 18, 2019
Approved For Pub - Principal Register
Dec 18, 2019
Examiner's Amendment Entered
Dec 18, 2019
Notification Of Examiners Amendment E-Mailed
Dec 18, 2019
Examiners Amendment E-Mailed
Dec 18, 2019
Examiners Amendment -Written
Dec 18, 2019
Previous Allowance Count Withdrawn
Dec 10, 2019
Withdrawn From Pub - Og Review Query
Nov 22, 2019
Approved For Pub - Principal Register
Nov 13, 2019
Teas/Email Correspondence Entered
Nov 12, 2019
Correspondence Received In Law Office
Nov 12, 2019
Teas Response To Office Action Received
Jun 1, 2019
Refusal Processed By Ib
May 11, 2019
Non-Final Action Mailed - Refusal Sent To Ib
May 11, 2019
Refusal Processed By Mpu
Apr 21, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Apr 20, 2019
Non-Final Action Written
Apr 17, 2019
Assigned To Examiner
Apr 12, 2019
Application Filing Receipt Mailed
Apr 8, 2019
New Application Office Supplied Data Entered In Tram
Apr 4, 2019
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24